Article Versions Notes

Mali A, Franci G, Zannella C, Chianese A, Anthiya S, López-Estévez AM, Monti A, De Filippis A, Doti N, Alonso MJ, et al. Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43. Pharmaceutics. 2023; 15(6):1621. https://doi.org/10.3390/pharmaceutics15061621

Mali, Avinash, Gianluigi Franci, Carla Zannella, Annalisa Chianese, Shubaash Anthiya, Ana M. López-Estévez, Alessandra Monti, Anna De Filippis, Nunzianna Doti, María José Alonso, and et al. 2023. "Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43" Pharmaceutics 15, no. 6: 1621. https://doi.org/10.3390/pharmaceutics15061621

Mali, A., Franci, G., Zannella, C., Chianese, A., Anthiya, S., López-Estévez, A. M., Monti, A., De Filippis, A., Doti, N., Alonso, M. J., & Galdiero, M. (2023). Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43. Pharmaceutics, 15(6), 1621. https://doi.org/10.3390/pharmaceutics15061621